SERPINA1 and cystic fibrosis: Gene therapy is considered to facilitate treatment opportunities for incurable pulmonary diseases including monogenetic defects like cystic fibrosis, alpha1-antitrypsin deficiency and complex disease like asthma and lung cancer [19].